MorphoSys AG | Income Statement

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
77,960.00
63,978.00
106,223.00
49,744.00
66,790.80
76,442.50
SG&A Expense
61,727.00
61,655.00
86,763.00
95,926.00
119,877.30
111,768.30
EBIT
11,110.00
1,684.00
16,364.00
49,619.00
57,116.50
40,872.40
Unusual Expense
1,624.00
4,079.00
2,310.00
10,111.00
10,783.00
20,346
Non Operating Income/Expense
870.00
631.00
98.00
1,096.00
712.20
875.30
Interest Expense
22.00
181.00
54.00
55.00
414.90
224.60
Pretax Income
10,681.00
4,309.00
20,625.00
59,864.00
68,790.10
60,476.80
Income Tax
3,310.00
1,296.00
5,724.00
519.00
1,036.40
4,304.70
Consolidated Net Income
7,371.00
3,013.00
14,901.00
60,383.00
69,826.50
56,172.10
Net Income
7,371.00
3,013.00
14,901.00
60,383.00
69,826.50
56,172.10
Net Income After Extraordinaries
1,420.00
3,013.00
14,901.00
60,383.00
69,826.50
56,172.10
Net Income Available to Common
5,679.00
3,013.00
14,901.00
60,383.00
69,826.50
56,172.10
EPS (Basic)
0.54
0.12
0.57
2.28
2.41
1.79
Basic Shares Outstanding
24,504.00
25,904.00
26,019.90
26,443.40
28,947.60
31,338.90
EPS (Diluted)
0.54
0.12
0.57
2.27
2.41
1.79
Diluted Shares Outstanding
24,763.10
26,190.30
26,244.30
26,543.20
28,947.60
31,338.90
EBITDA
15,920.00
2,450.00
19,819.00
45,855.00
53,086.50
37,122.40
Other Operating Expense
313.00
127.00
359.00
327.00
-
-
Non-Operating Interest Income
347.00
1,004.00
1,907.00
1,017.00
236.40
90.90

About MorphoSys

View Profile
Address
SemmelweisstraƟe 7
Planegg Bayern (Bavaria) 82152
Germany
Employees -
Website http://www.morphosys.de
Updated 07/08/2019
MorphoSys AG engages in the development of antibodies for therapeutic, diagnostics, and research applications. It operates through the Proprietary Development and Partnered Discovery segments. The Proprietary Development segment combines proprietary research and development of therapeutic compounds.